RxDoctor Payments Data

Jason Ross, MD

Anesthesiology · Chicago, ILNPI 1952833329

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Abbott at 48.7% of the total. Among anesthesiology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$33,457in general payments, 2019–2025

Across 323 payments — averaging $103.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$16K
  • Boston Scientific$6K
  • Saluda Medical Americas, Inc.$4K
  • Medtronic$4K
  • SPR Therapeutics, Inc$909
  • Biotronik NRO, Inc.$789
  • plus $1K from 9 others

What the payments were for

  • Consulting fees$1,3504%
  • Speaking & faculty fees$4,25013%
  • Travel & lodging$9,35928%
  • Food & beverage$18,49855%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,457 in reported general payments places this provider in the 95th percentile of 1,980 anesthesiology providers in Illinois.

See all anesthesiology providers in Illinois

Medicare billing

Part B allowed, 2024
$202,466
Medicare patients
496
Services billed
1,978

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl16$9,320
Buprenorphine20$6,657
Gabapentin186$3,226
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen103$2,622
Lidocaine24$1,371
Pregabalin75$1,317
Tramadol Hcl100$1,046
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen27$993
Tizanidine Hcl115$753
Diclofenac Sodium29$488
Morphine Sulfate ErMorphine Sulfate20$444
Oxycodone Hcl28$442
Hydromorphone Hcl16$399
Buprenorphine Hcl16$324
Duloxetine Hcl17$267

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →